Wanda Sykes' provocative Super Bowl ad tackles breast cancer awareness. Discover how early detection saved her life and could save millions more.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

In his next chief executive gig after securing the $14 billion acquisition of Karuna Therapeutics Inc., Bill Meury has now locked in another big biotech deal.

About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...

Q4 2024 Earnings Call Transcript January 31, 2025 Novartis AG beats earnings expectations. Reported EPS is $1.98, ...

Novartis’ results show the firm humming along nicely in 2024, with sales driven by continued strong performance from its ...

Good morning and good afternoon, and welcome to the Novartis Q4 2024 results release conference call and live webcast.

Ad hoc announcement pursuant to Art. 53 LR Full year Net sales grew +12% (cc1, +11% USD) with core operating income1 up +22% (cc, +19% USD) Sales growth driven by continued strong performance ...

Net sales grew +12% (cc 1, +11% USD) with core operating income 1 up +22% (cc, +19% USD) Sales growth driven by continued st ...

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to ...

Novartis AG NVS, a Swiss pharma giant ... Increased demand has likely fueled multiple sclerosis drug Kesimpta’s sales in the to-be-reported quarter. The Zacks Consensus Estimate and our model ...